For US Healthcare Professionals Only
Filter
Treatment characteristics and healthcare resource utilization among patients with generalized myasthenia gravis initiating rozanolixizumab in the United States
Patient treatment preferences in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
Sustained minimal symptom expression in generalized myasthenia gravis: A 120-week post hoc analysis of RAISE-XT
Missed opportunities for pharmacist intervention among Medicare Fee-for-Service beneficiaries with myasthenia gravis: A real-world claims analysis
Comprehensive care goals in myasthenia gravis: Expert consensus recommendations using the RAND/UCLA appropriateness method
Response to rozanolixizumab across treatment cycles in patients with generalized myasthenia gravis: A post hoc analysis of final pooled Phase 3 data
Disruptive Sleep in Developmental and Epileptic Encephalopathies: Interim Results of a Caregiver Survey
Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results From a Phase 3, Randomized, Double-blind, Placebo-controlled study
Streamlining the Process of Caregiving for a Loved One With Dravet or Lennox-Gastaut Syndrome
Association of Fenfluramine Treatment and Everyday Executive Functioning in Adults With Lennox-Gastaut Syndrome
Healthcare Resource Utilization, Antiseizure Medication Claims, and Treatment Persistence in Patients With Lennox-Gastaut Syndrome Receiving Fenfluramine in the United States
Prevalence, Treatment Patterns, and Healthcare Resource Utilization Among Patients With CDKL5 Deficiency Disorder: Retrospective Analysis of US Claims Data
Mortality Rates and Risk Factors Among Patients With Lennox-Gastaut Syndrome or Dravet Syndrome
Loss of Productivity, Seizure Worry, and Patient and Caregiver Quality of Life Associated With Prolonged Seizures: Results From a Global Real-World Point-in-Time Study
Describing the Population of Patients With Prolonged Seizures: US Subgroup Results From a Global Real-World Point-in-Time Study
Patient and Caregiver Perceptions of Acute Seizure Medications and the Rapid and Early Seizure Termination (REST) Approach: Qualitative Interviews
Patient and Caregiver Preferences for Acute Seizure Medications: A Quantitative Survey
Seizure Duration and Time-point Cutoffs for Statistically Defining a Prolonged Seizure: A Post-Hoc Analysis of the SCORE Video-EEG Database
Costs, Healthcare Resource Utilization, and Patient Characteristics Associated With CDKL5 Deficiency Disorder: A Retrospective Analysis of the US Closed Claims Database MarketScan
Understanding Frequency and Characteristics of Prolonged Seizures Using Seizure Diary Data